ARF1 and cancer: As far as we are aware, this new Arf1 inhibitor is the pioneering drug that activates a dual anticancer therapy by promoting cancer stem cell aging and anti‐tumor immunity and may lay the groundwork for additional therapeutics targeting this dual process.